Active	Status	Sponsor type	Region	Phase	Filter
5 Active 0 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Narayanan, Govindarajan
INJECTABL-1, NCT05688280 / 2022-000176-19: Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS	Active, not recruiting	1/2	42	Europe, US	1.0% IP-001 for Injection, IP-001	Immunophotonics, Inc., Immunophotonics Inc.	Metastatic Solid Tumor, Colon Cancer, Nonsmall Cell Lung Cancer, Soft Tissue Sarcoma	02/25	02/25
#HOPE4LIVER US, NCT04572633: The HistoSonics System for Treatment of Primary and Metastatic Liver Tumors Using Histotripsy	Active, not recruiting	N/A	47	US	HistoSonics System, Histotripsy	HistoSonics, Inc.	Liver Neoplasms, Hepatocellular Carcinoma, Liver Metastases	01/23	07/26
Barbery, Katuska
No trials found